StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
INSMINSMED Inc
stockpulse.co.kr
Nasdaq
$93.66▲ 0.23%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $20.30BShares out 2.200M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

20
  • 4d agoAfter-hours26.10.21 06:08
    4Ownership#●●●

    INSMED Inc

    Insmed Inc insider Utpal Koppikar reported a transaction involving company shares on October 19, 2026. This filing is a Form 4 statement submitted to the SEC regarding changes in beneficial ownership.…more

    $93.66+0.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 4d agoAfter-hours26.10.21 06:07
    4Ownership

    INSMED Inc

    Insmed Inc executive Paul Hudson reported a change in beneficial ownership of securities on October 19, 2026. This filing serves as a standard Form 4 disclosure regarding changes in insider stock holdings.…more

    $93.66+0.23%vs prev close
    View filingShare
  • 4d agoAfter-hours26.10.21 06:05
    3Ownership

    INSMED Inc

    Insmed executive Utpal Koppikar has filed a Limited Power of Attorney to delegate SEC reporting responsibilities to designated attorneys-in-fact. This is an administrative procedure to facilitate compliance with reporting requirements under the Securities Exchange Act for company officers and directors.…more

    $93.66+0.23%vs prev close
    View filingShare

19 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.5Regular26.10.06 00:59
    Bullish#●●●#●●●

    Insmed Shares Drop 7% Following CFO Resignation

    Insmed shares fell nearly 7% as investors reacted to the news of the CFO's upcoming departure. Despite the company reaffirming its 2026 financial guidance, the stock faced downward pressure.…more

    $93.66+0.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 10.5Pre-market26.10.05 20:07

    ●●●●●●●● ●●●●● ●●●●●●

    Insmed has reaffirmed its full-year 2026 revenue guidance for its key products, BRINSUPRI and ARIKAYCE. The company maintains its growth outlook based on continued operational momentum.…more

    $93.66+0.23%vs prev close
    ShareBenzinga
  • 10.5Pre-market26.10.05 20:05

    ●●●●●●●● ●●●●● ●●●●●●

    Insmed's Chief Financial Officer Sara Bonstein will step down from her position on October 30. Investors should monitor potential changes in financial strategy following this leadership departure.…more

    $93.66+0.23%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →